Our Research

OUR RESEARCH

science

It All Starts with Science

The pet wellness market with hemp derivatives has garnered significant attention from pet parents seeking natural solutions and alternatives for their companions’ mobility and joint health.

The EVS Mission Statement

5 Years of Scientific Studies at Leading U.S. Universities

At Enhanced Vet Sciences (EVS), our mission is to provide trusted, next-generation, all-natural daily pet mobility hard chews and soft bits that are palatable, easy to deliver, promote mobility, and can be trusted.

Since 2018, EVS has funded multi-million-dollar scientific studies conducted by Lincoln Memorial University (LMU), the University of Kentucky, and other research facilities, including research farms and state-of-the-art greenhouses. Early studies focused on general CBD and traditional products, while later research emphasized broad-spectrum hemp with no detectable THC and freeze-dried formulations—the foundation of our final products, which also feature all-natural beef and fish oil (omega-3s).

All research was peer-reviewed and published in 2023, highlighting EVS’s commitment to scientific validation. The primary areas of study included:

  1. 1.  Palatability
  2. 2.  Trust
  3. 3.  Daily Usage
  4. 4.  Mobility
  5. 5.  Easy Delivery

Additionally, between 2018 and 2023, EVS focused on research and development of its genetics, broad-spectrum hemp formulations, and daily pet mobility chews and soft bits. In 2023, all research was defended and published, underscoring our commitment to scientific validation.

In February 2024, EVS was honored to become a member of the National Animal Supplement Council (NASC), the highest certification in our category, reflecting our dedication to quality and safety.

EVS products are designed to be compatible with other treatments and do not interfere with their performance.

The company invested multi-million dollars in collaboration with leading U.S. universities over a five-year research program to investigate hemp-derived pet health supplements. During the early phase of investigation, a CBD isolate formulation containing ≤0.03% THC was evaluated at an initial dose of approximately 1.5 mg per kilogram of body weight. Therapeutic response during this phase was limited. Dose escalation of the isolate formulation did not result in consistent or clinically meaningful improvement, indicating limitations associated with isolate-based delivery under the conditions evaluated.

easytodeliver

Palatability

In university studies veterinary shows and national sample offerings, dogs, cats and horses loved the tasty hard chews and soft bits.

Safety-studies

Trust

The EVS Maximum strength BSH blend products were well tolerated in healthy dogs with a daily usage of 5mg per kg of body weight per day , these products do not pose a significant risk in long term use

marliese-streefland-2l0CWTpcChI-unsplash

Daily Usage

For dogs, our studies used 5 mg per kg body weight and for horses 1mg per pound body weight for daily usage.

Please note that cats were not included in the studies involving broad spectrum hemp. Cat Products are only available in Glucosamine Chondroitin GC Blend.

alvan-nee-1316903-unsplash

Mobility Support

Our 5-year studies at leading US universities concluded that our broad spectrum hemp (BSH) daily mobility chews and soft bits support mobility and joint health in dogs and horses.

Easy to Deliver

Parents no longer need to force products onto their four-legged friends. The EVS hard chews and soft bits are easy to deliver.

EVS: Developing Safe, THC-Free Hemp-Derivative Supplements for Pets

Read the complete five-year EVS research overview here.

Mission Accomplished After 5 Years.

EVS next generation daily mobility chews and soft bits are palatable, easy to deliver, promotes mobility and can be trusted.

Loved by Pets, Trusted by Pet Parents.

To learn more about our research and published papers, please email us at support@enhancedvetsciences.com

Disclaimer

The products described in this research summary are dietary supplements, not drugs. They are not intended to diagnose, treat, cure, or prevent any disease. These products are intended for supplemental use only and are not designed or classified as food or treats. The information presented is for research and informational purposes only and should not be interpreted as medical or veterinary advice.

EVS is a member of the National Animal Supplement Council (NASC), the leading authority in the animal supplement category, relied upon by regulators, major retailers, and other industry stakeholders. NASC membership is subject to change as applicable laws and regulations evolve.

All products are manufactured under strict Standard Operating Procedures (SOPs) in facilities inspected for GMP, ISO 9001, and other quality standards. Each batch is fully tracked and traceable, supported by a Certificate of Analysis (COA), and tested in qualified third-party laboratories prior to formulation and after final release. These measures ensure that tetrahydrocannabinols (THC) are not detected, supporting safety, consistency, and regulatory compliance.

Our formulations are specifically designed to exclude THC entirely, rather than relying on compliance with maximum allowable thresholds.

EVS: Developing Safe, THC-Free Hemp-Derivative Supplements for Pets